SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-020086
Filing Date
2024-03-05
Accepted
2024-03-05 15:20:23
Documents
1
Period of Report
2024-01-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 4086
  Complete submission text file 0001213900-24-020086.txt   5586
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INMED PHARMACEUTICALS INC. SUITE 310 - 815 HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address
MANCINI ALEXANDRA DIANE JANET (Reporting) CIK: 0001817890 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39685 | Film No.: 24719909